Mirador Therapeutics
Develops next-generation therapies for immune-mediated inflammatory and fibrotic diseases
$250MSeries B
Role not disclosedLoading investors…
Activity from announced rounds
Develops next-generation therapies for immune-mediated inflammatory and fibrotic diseases
Develops medicines targeting historically undruggable protein targets in cancer